Breast cancer test 'offers hope'

A new test that identifies seven distinct types of breast cancer offers new hope to women with the disease, scientists claim. The tumour sample test could be available within two years and is expected to lead to more personalised treatments.

Live updates

New test 'could be step towards personalised care'

Breast Cancer Campaign chief executive Baroness Delyth Morgan said a new test "could be a realistic step towards making the holy grail of personalised medicine a reality".

Baroness Morgan said:

The days of one size fits all treatment are well and truly in the past.

We need to ensure the life-saving and life-extending treatments we already have in the clinic are used more effectively - directing the right treatments to those who will benefit, and sparing others from unnecessary side effects, so that by 2050 we can achieve our ambition to overcome breast cancer.

New test 'identifies seven classes of breast cancer'

A new breast cancer test identifies seven classes of the disease, defined by different combinations and levels of 10 proteins found in breast cancer cells.

Each cancer type has a different effect on patient survival, the scientists said. Credit: Rui Vieira/PA Wire

Each cancer type has a different effect on patient survival, according to the scientists whose findings are reported in the British Journal of Cancer.

The technology needed to measure the proteins in tumour samples already exists in most pathology laboratories across the UK, lead researcher Dr Andy Green, from the University of Nottingham, said.

Advertisement

Scientists say new breast cancer test 'offers hope'

A new test that identifies seven distinct types of breast cancer offers new hope to women with the disease, scientists claim.

The tumour sample test could be available within two years and is expected to lead to more personalised treatments.

Scientists at the University of Nottingham were funded by the Breast Cancer Campaign. Credit: Rui Vieira/PA Archive

Identifying more biomarkers will help doctors tailor therapy plans that better suit their patients, avoiding over or under treatment, they said.

Scientists funded by the Breast Cancer Campaign looked for signature biomarkers in 1,073 tumour samples from the charity's tissue bank. They found that 93% fitted perfectly into one of seven classes. Another 7% had mixed characteristics and were harder to categorise.

Back to top